# Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer

> **NCT00287911** · PHASE1 · COMPLETED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 18 (actual)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** topotecan hydrochloride
- **RADIATION:** brachytherapy
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00287911
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2017-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00287911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00287911, "Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00287911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*